老年急性嗜酸性粒细胞肺炎1例并文献复习

doi:10.3969/j.issn.1004-583X.2022.10.009

摘要/Abstract

摘要：

目的探讨急性嗜酸性粒细胞肺炎的临床特点及诊疗方法。方法对该患者行经气管肺部灌洗和肺组织活检,并给予糖皮质激素治疗,观察患者肺部影像学变化趋势。结果经气管肺部灌洗和肺组织活检确诊后,给予糖皮质激素治疗,患者症状明显好转,胸部炎症渗出完全吸收。结论急性嗜酸性粒细胞肺炎的临床症状不典型,可经气管肺部灌洗和肺组织活检确诊,且糖皮质激素治疗快速有效,一般预后良好。

关键词: 肺嗜酸粒细胞增多, 肺炎, 支气管肺泡灌洗, 糖皮质激素类

Abstract:

Objective To investigate the clinical characteristics, diagnosis and treatment of acute eosinophilic pneumonia. Methods The bronchoalveolar lavage and lung biopsy were performed in this patient, and glucocorticoid was managed, the pulmonary iconography result was recorded. Results The therapeutic result showed that the symptoms improved significantly, the pulmonary inflammatory exudates were completely absorbed. Conclusion This findings demonstrates that clinical symptoms of acute eosinophilic pneumonia are atypical, the glucocorticoid therapy following bronchoalveolar lavage and lung biopsy is quick and effective, with favourable prognosis.

Key words: pulmonary eosinophilia increased, pneumonia, bronchoalveolar lavage, glucocorticoids

中图分类号:

R563.1

臧佳佳, 高艳锋, 韩书芝, 平芬. 老年急性嗜酸性粒细胞肺炎1例并文献复习[J]. 临床荟萃, 2022, 37(10): 931-933.

Zang Jiajia, Gao Yanfeng, Han Shuzhi, Ping Fen. Acute eosinophilic pneumonia in the elderly: A case report and literature review[J]. Clinical Focus, 2022, 37(10): 931-933.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://huicui.hebmu.edu.cn/CN/10.3969/j.issn.1004-583X.2022.10.009

https://huicui.hebmu.edu.cn/CN/Y2022/V37/I10/931

图/表 4

图1 入院当天胸部CT a.左肺上叶;b.右肺下叶斑片状高密度影,边缘模糊

图2 入院第23天胸部CT a.左肺上叶;b.右肺下叶斑片状高密度影病变范围稍大,病变密度减低

图3 肺组织活检(HE染色, ×40) a.右肺下叶基底段;b.左肺上叶尖后段

图4 出院2个月复查胸部CT a.左肺上叶;b.右肺下叶病灶基本完全吸收

参考文献 19

[1]	Allen J, Wert M. Eosinophilic pneumonias[J]. J Allergy Clin Immunol Pract, 2018, 6(5): 1455-1461. doi: S2213-2198(18)30269-1 pmid: 29735405
[2]	Chaaban T. Acute eosinophilic pneumonia associated with non-cigarette smoking products: A systematic review[J]. Adv Respir Med, 2020, 88(2): 142-146. doi: 10.5603/ARM.2020.0088 pmid: 32383466
[3]	Suzuki Y, Suda T. Eosinophilic pneumonia: A review of the previous literature, causes, diagnosis, and management[J]. Allergol Int, 2019, 68(4): 413-419. doi: S1323-8930(19)30067-X pmid: 31253537
[4]	Allen JN, Pacht ER, Gadek JE, et al. Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure[J]. N Engl J Med, 1989, 321(9): 569-574. doi: 10.1056/NEJM198908313210903 URL
[5]	Zhang XD, Gong HH, Gao JM. Clinical analysis of 40 patients with eosinophilic lung diseases in Peking Union Medical College Hospital[J]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 2018, 40(2): 170-177.
[6]	Kadyrova A, Antipina I, Kyrbasheva I, et al. CT patterns and differential criteria for acute eosinophilic pneumonia and COVID-19 pneumonia[J]. Clin Case Rep, 2021, 9(10): e04890.
[7]	Lozano Buj A, Bonnin Vilaplana M,, Jolis Olive R. Acute eosinophilic pneumonia with peripheric alveolar infiltrates[J]. Med Clin (Barc), 2019, 153(3): 126-127. doi: 10.1016/j.medcli.2018.05.035 URL
[8]	Ota K, Sasabuchi Y, Matsui H, et al. Age distribution and seasonality in acute eosinophilic pneumonia: Analysis using a national inpatient database[J]. BMC Pulm Med, 2019, 19(1): 38. doi: 10.1186/s12890-019-0800-3 pmid: 30755187
[9]	Fayyaz B. Acute eosinophilic pneumonia associated with smoking: A case report[J]. J Community Hosp Intern Med Perspect, 2018, 8(3): 119-122.
[10]	Zimmer MA, Haffner E, Weisser CW, et al. Daptomycin-induced eosinophilic pneumonia associated with an early endoprosthesis infection[J]. Anaesthesist, 2020, 69(6): 414-420. doi: 10.1007/s00101-020-00765-y pmid: 32270225
[11]	van Oortegem A, Meurice JC, Verdaguer M, et al. Case report of severe acute eosinophilic pneumonia induced by amoxicillin[J]. Rev Mal Respir, 2021, 38(5): 524-529. doi: 10.1016/j.rmr.2021.03.010 pmid: 33902969
[12]	de Giacomi F, Decker P A, Vassallo R, et al. Acute eosinophilic pneumonia: Correlation of clinical characteristics with underlying cause[J]. Chest, 2017, 152(2): 379-385. doi: S0012-3692(17)30360-4 pmid: 28286263
[13]	Araujo M, Correia S, Lima AL, et al. SARS-CoV-2 as a trigger of eosinophilic pneumonia[J]. Pulmonology, 2022, 28(1): 62-64. doi: 10.1016/j.pulmoe.2021.07.007 URL
[14]	de Giacomi F, Vassallo R, Yi ES, et al. Acute eosinophilic pneumonia. Causes, diagnosis, and management[J]. Am J Respir Crit Care Med, 2018, 197(6): 728-736. doi: 10.1164/rccm.201710-1967CI URL
[15]	Somoza-Cano FJ, Makadia A, Cruz-Peralta MP, et al. Acute eosinophilic pneumonia secondary to daptomycin[J]. Cureus, 2021, 13(11): e19403.
[16]	Yoshida K, Morishima Y, Ishii Y, et al. Clinical significance of invariant natural killer T cells and IL-5 in acute eosinophilic pneumonia[J]. Allergol Int, 2021, 70(2): 258-261. doi: 10.1016/j.alit.2020.09.013 pmid: 33191121
[17]	Akaba T, Kondo M, Hara K, et al. Tryptase and IL-33 in bronchoalveolar lavage fluid may predict the types of eosinophilic pneumonia and disease recurrence[J]. Int Arch Allergy Immunol, 2022, 183(4): 415-423. doi: 10.1159/000520180 URL
[18]	Bartal C, Sagy I, Barski L. Drug-induced eosinophilic pneumonia: A review of 196 case reports[J]. Medicine, 2018, 97(4): e9688. doi: 10.1097/MD.0000000000009688 URL
[19]	Cottin V. Eosinophilic lung diseases[J]. Clin Chest Med, 2016, 37(3): 535-556. doi: 10.1016/j.ccm.2016.04.015 pmid: 27514599